Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Clinical trial NCT04004572 · COMPLETED

Trial details

NCT number: NCT04004572
Sponsor: Rong Tao
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Start date: 2019-07-01
Primary completion: 2024-12-30
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.